AEZS - 1.02 Pre-market now at 1.50/1.53 Aeterna Zentaris Soars 30% in Post-Market; FDA Accepts Macrilen New Drug Re-Submission; Plans Q1 Launch http://stockcharts.com/c-sc/sc?s=AEZS&p=D&b=5&g=0&i=t05865600032&r=1500466022538 http://stockcharts.com/c-sc/sc?s=AEZS&p=W&b=5&g=0&i=t83241556625&r=1500466003919